Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 欧普康视是一家专业于眼健康和近视防控技术与服务的高新技术企业，专注眼视光产品及相关配套产品的研发、生产、销售，以及眼视光服务，是国内首家上市的眼视光高新科技企业，业务包括“眼科及视光医疗器械（产品）”与“眼视光服务”二大板块，目前主要业务为角膜塑形镜等硬性接触镜类产品及配套护理产品的生产和销售，正在向“全面的眼视光产品研发制造及专业的眼视光服务企业”发展。公司目前的主要产品是角膜塑形镜及其护理产品，用于视力矫正和近视控制。角膜塑形镜根据用户的角膜几何形状和屈光度个性化设计制作，通过暂时性的改变角膜形态达到暂时性降低近视度数的效果，用户可以睡觉时配戴，起床后摘下，整个白天裸眼视力清晰。临床研究表明，长期配戴角膜塑形镜可以减少或消除旁中心远视离焦，减缓眼轴的增长，从而显著减缓近视度数的加深。角膜塑形镜已被列入国家卫健委2018年6月发布的《近视防控指南》和2019年10月发布（2021年10月更新）《儿童青少年近视防控适宜技术指南》，受到眼科专家和用户的认可。公司是目前国内及全球领先的角膜塑性镜研发与生产企业。拥有“梦戴维”和“DreamVision”二个塑形镜品牌。其中，梦戴维品牌角膜塑形镜已应用十八年，用户约190万，在这类产品中具有较高的知名度，DreamVision产品则具有智能化、个性化等特点，技术上独具一格。公司采用经销、直销、直营相结合的模式。在经销渠道方面，公司拥有一批已取得医疗器械经营许可证的经销商，授权他们向某个特定区域，或某些眼视光服务机构销售公司的产品；对于一些民营医院和公司（及子公司）所在区域的非民营医院，公司或子公司将产品直接销往医院；同时，公司拥有控股和参股的视光服务终端360多家，这些服务终端从事全面的视光技术服务和全视光产品销售，包括公司自研自产的产品。公司为客户（经销商和视光服务机构）提供技术培训、规范经营培训、验配技术支持、规范性督查、产品售后服务、安全风险防范协助等专业化服务。公司主营产品角膜塑形镜为个性化定制，客户通过公司自主开发的订单信息管理系统下达订单，该系统还包含产品的设计、生产、质检、物流，客户下单、订单审核、生产计划、加工、检验、发货完全在信息系统完成，实现了过程全追溯管理。
Main Business 眼视光产品及相关配套产品的研发、生产、销售，以及眼视光服务
Legal Representative 陶悦群
Top Executives
董事长：陶悦群
董事：黄彤舸,卫立治,付志英,承毅华,施贤梅
独立董事：许立新,唐民松,许强
Top 5 Shareholder
Shareholder name Nature Holding Date
陶悦群限售股+流通A股33.32%30/09/2024
南京欧陶信息科技有限公司流通A股13.69%30/09/2024
合肥欧普民生投资管理合伙企业（有限合伙）流通A股3.75%30/09/2024
中国银行股份有限公司－华宝中证医疗交易型开放式指数证券投资基金流通A股2.02%30/09/2024
中国工商银行股份有限公司－易方达创业板交易型开放式指数证券投资基金流通A股1.50%30/09/2024
Company Secretary 施贤梅
Solicitors 安徽天禾律师事务所
Auditors 容诚会计师事务所（特殊普通合伙）
Tel No 0551-62952208
Fax No 0551-65319181
Website www.orthok.cn/
Email autekchina@126.com
Company Address
Register: 安徽省合肥市高新区望江西路4899号
Office: 安徽省合肥市高新区望江西路4899号
Listing Date 17/01/2017
Shares Capital
Shares Capital: 896,677,672
Total A Share: 896,677,672
Listed A Share: 668,494,760
Non-tradable A Share: 228,182,912
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.746
DPS(RMB)* ¥ 0.223
NBV Per Share(RMB)* ¥ 4.850
Market Capitalization(RMB) 13.577B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.